haloperidol has been researched along with nafadotride in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (47.06) | 18.2507 |
2000's | 7 (41.18) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
Braun, J; Brodbeck, R; Chen, X; Primus, R; Thurkauf, A; Wasley, JW; Yuan, J | 1 |
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
Wermuth, CG | 1 |
Costentin, J; Diaz, J; Garrido, F; Griffon, N; Lévesque, D; Mann, A; Sautel, F; Schwartz, JC; Simon, P; Sokoloff, P | 1 |
Barik, S; de Beaurepaire, R | 2 |
Griffon, N; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
Clifford, JJ; Waddington, JL | 1 |
Garimelli, B; Levant, B; Merchant, KM; Shafer, RA | 1 |
Maj, J; Rogóz, Z; Skuza, G | 1 |
Schlicker, E; Sokoloff, P; Stark, H; Weber, B | 1 |
Biala, G; Duarte, C; Hamon, M; Le Bihan, C; Thiébot, MH | 1 |
Gál, K; Gyertyán, I | 1 |
Gomita, Y; Kawasaki, H; Kimoto, S; Kitagawa, K; Kitamura, Y; Sagara, H; Sendo, T; Shibata, K | 1 |
Banasikowski, TJ; Beninger, RJ; MacLeod, LS | 1 |
Banasikowski, TJ; Beninger, RJ | 1 |
2 review(s) available for haloperidol and nafadotride
Article | Year |
---|---|
Selective optimization of side activities: another way for drug discovery.
Topics: Animals; Biological Availability; Combinatorial Chemistry Techniques; Databases, Factual; Drug Design; Humans; Patents as Topic; Pharmaceutical Preparations; Structure-Activity Relationship | 2004 |
The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approaches.
Topics: Animals; Antipsychotic Agents; Dopamine Antagonists; Haloperidol; Humans; Locomotion; Naphthalenes; Pyrrolidines; Receptors, Dopamine; RNA, Messenger; Schizophrenia | 1995 |
15 other study(ies) available for haloperidol and nafadotride
Article | Year |
---|---|
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
NGB 2904 and NGB 2849: two highly selective dopamine D3 receptor antagonists.
Topics: Animals; CHO Cells; Cricetinae; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Fluorenes; Humans; Kinetics; Piperazines; Rats; Receptors, Dopamine D2; Receptors, Dopamine D3; Transfection | 1998 |
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
Evidence for a functional role of the dopamine D3 receptors in the cerebellum.
Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Haloperidol; Locomotion; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sulpiride | 1996 |
Antipsychotics with inverse agonist activity at the dopamine D3 receptor.
Topics: Animals; Antipsychotic Agents; Calcium; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; DNA Replication; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Flupenthixol; Glioma; Haloperidol; Humans; Hybrid Cells; Naphthalenes; Neuroblastoma; Pertussis Toxin; Phenothiazines; Pimozide; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Risperidone; Salicylamides; Second Messenger Systems; Sulpiride; Tetrahydronaphthalenes; Tumor Cells, Cultured; Virulence Factors, Bordetella | 1996 |
Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach.
Topics: Animals; Behavior, Animal; Biphenyl Compounds; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Grooming; Haloperidol; Indans; Male; Motor Activity; Naphthalenes; Piperazines; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D3; Stereotyped Behavior | 1998 |
Increased levels of proneurotensin/neuromedin N mRNA in rat striatum and nucleus accumbens induced by 7-OH-DPAT and nafadotride.
Topics: Animals; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Gene Expression Regulation; Haloperidol; Male; Naphthalenes; Neurotensin; Nucleus Accumbens; Peptide Fragments; Protein Precursors; Pyrrolidines; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Transcription, Genetic | 1999 |
The anticataleptic effect of 7-OH-DPAT: are dopamine D3 receptors involved?
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Catalepsy; Dextroamphetamine; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Fluphenazine; Haloperidol; Hyperkinesis; Levodopa; Locomotion; Male; Naphthalenes; Pyrrolidines; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reserpine; Tetrahydronaphthalenes | 1999 |
Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists.
Topics: Animals; Azepines; Binding Sites; CHO Cells; Cricetinae; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guinea Pigs; Haloperidol; Male; Naphthalenes; Norepinephrine; Pyrrolidines; Quinpirole; Receptors, Dopamine D2; Retina; Substrate Specificity | 2001 |
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Analysis of Variance; Animals; Apomorphine; Benzazepines; Benzopyrans; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Feeding Behavior; Haloperidol; Male; Naphthalenes; Pyrroles; Pyrrolidines; Quinolines; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology; Sulpiride; Tetrahydronaphthalenes | 2003 |
Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference.
Topics: Animals; Avoidance Learning; Benzazepines; Benzopyrans; Cocaine; Conditioning, Classical; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Indans; Male; Naphthalenes; Nitriles; Oxazines; Piperazines; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology; Reward; Spatial Behavior; Substance-Related Disorders; Tetrahydroisoquinolines; Tetrahydronaphthalenes | 2003 |
Dopamine D3 modulation of locomotor activity and sleep in the nucleus accumbens and in lobules 9 and 10 of the cerebellum in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Amphetamine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Microinjections; Motor Activity; Naphthalenes; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Sleep; Sulpiride; Tetrahydronaphthalenes | 2005 |
Selegilin exerts antidepressant-like effects during the forced swim test in adrenocorticotropic hormone-treated rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Benzazepines; Cosyntropin; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Models, Animal; Monoamine Oxidase Inhibitors; Motor Activity; Naphthalenes; Pyrrolidines; Rats; Rats, Wistar; Receptors, Dopamine D3; Selegiline; Swimming; Time Factors | 2008 |
Comparison of nafadotride, CNQX, and haloperidol on acquisition versus expression of amphetamine-conditioned place preference in rats.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amphetamine; Animals; Conditioning, Psychological; Haloperidol; Male; Naphthalenes; Pyrrolidines; Rats; Rats, Wistar; Receptors, AMPA; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2012 |
Reduced expression of haloperidol conditioned catalepsy in rats by the dopamine D3 receptor antagonists nafadotride and NGB 2904.
Topics: Animals; Behavior, Animal; Catalepsy; Conditioning, Classical; Disease Models, Animal; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Fluorenes; Haloperidol; Male; Motor Activity; Naphthalenes; Piperazines; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D3; Spatial Behavior; Time Factors | 2012 |